Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.
about
Treatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysisMeta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan.Helicobacter pylori therapy: Present and futureA Comparison between Hybrid and Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial.Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance.Current options for the treatment of Helicobacter pylori.Treatment of Helicobacter pylori infection 2013.Eradication of Helicobacter pylori infection: which regimen first?Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition.Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance.Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis.Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era.Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection.Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis.Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies.Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey).First-line Bismuth-containing Five-day Concomitant Quintuple Therapy for Helicobacter Pylori Eradication.Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.Challenging the dogma: a randomized trial of standard vs. half-dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infectionDoes standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea?Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial.
P2860
Q26799348-CC19ACCB-D8D3-49DD-BC79-1CB8EEC85E75Q33627553-D283C37E-3EC0-405D-994B-040275EFC974Q35598058-9CE41A69-922D-41BC-9B43-AA7550C0F952Q35841617-9D84FDEF-6261-4A3F-A48C-19B83B4B6D68Q36129001-F5EAD666-229A-401F-9052-8C3C4AEFA79AQ36220182-6119FC56-C121-49D9-B356-07D99BFF7CD4Q37302516-2DA3159D-3982-4788-99F5-94A5CB040573Q37649367-B5F0AAAD-1368-4760-AB3B-4B6EA308A02CQ38075061-321B44E9-6125-4AFD-B31B-BDC880275C50Q38134877-D19CEB26-6662-4770-BD41-F738F22C2D66Q38191565-EC54AD14-B832-494D-800F-3E2FC7E209B4Q38192615-95F1DDD1-0106-4D8B-90E3-386539767045Q38206548-CBC99495-0837-4EAE-A576-CFC12CE68CFEQ38238745-E37A5582-4659-4D57-B3F8-3F4F9FAC77F5Q38240845-EAFDA73E-4D24-482E-877D-D1DBFDCA2D5AQ38266303-DC9E66CD-3D65-4933-91D3-0F19BEBC3974Q38578674-3C88BA59-AC54-4697-8F23-248FF6FEF264Q39135143-2B0FE262-1009-4EAC-9EE8-A1ED58343610Q39251528-293FA9F6-E188-42BA-894D-FA93BF5BF254Q39278632-9E75B2F0-AE0D-4D35-86CF-BE5350FFF6CDQ40314735-01E99BFE-2025-4268-AF2E-6D6CF79C9B6CQ41143975-97D0A8B9-8533-472B-B06C-84D3BEA4C901Q41442419-074D7906-93ED-4C54-A1D3-C723518A5588Q41682366-A9DFD710-056C-4BA7-89D4-9FA3E8D2242BQ42577095-EE87D1EC-BB29-4A68-9FDF-2E5BAFA29554Q47170175-6C086968-280F-4D62-8D87-AE6364BDB2FF
P2860
Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Comparative study of Helicobac ...... 7-day standard triple therapy.
@en
Comparative study of Helicobac ...... 7-day standard triple therapy.
@nl
type
label
Comparative study of Helicobac ...... 7-day standard triple therapy.
@en
Comparative study of Helicobac ...... 7-day standard triple therapy.
@nl
prefLabel
Comparative study of Helicobac ...... 7-day standard triple therapy.
@en
Comparative study of Helicobac ...... 7-day standard triple therapy.
@nl
P2093
P1476
Comparative study of Helicobac ...... 7-day standard triple therapy.
@en
P2093
Hoon Jai Chun
Hyung Joon Yim
Ja Seol Koo
Jai Hyun Choi
Jong Jae Park
Sang Woo Lee
Seung Young Kim
Sung Woo Jung
P356
10.1097/MCG.0B013E3182548AD4
P577
2013-01-01T00:00:00Z